Galileo Genomics
Montreal
About Galileo Genomics
Galileo genomics is a Montreal-based private genetics company that conducts research in Quebecers of French descent using cutting-edge technologies, to identify genes that cause disease, thus providing validated targets for creation of innovative and more effective therapies and diagnostics. The Quebec founder population is the largest such population worldwide, which facilitates rapid patient recruiting. Because of the relatively late founding of the population in the 17th century, the relatively small number of founders, rapid early population growth, minimal intermarriage with other groups, and loss of some family lines while others expanded dramatically, the population is among the most homogeneous and has among the highest genetic sharing of all major founder populations.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $32.0M
- Last round: Series Unknown (Jan 2004)
- Website: galileogenomics.com
Industries & Categories
Genetics, Medical, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/galileo-genomics-982313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.